Cartesian Therapeutics, Inc. (RNAC)
(Delayed Data from NSDQ)
$26.65 USD
+1.90 (7.68%)
Updated May 15, 2024 04:00 PM ET
After-Market: $26.55 -0.10 (-0.38%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth D Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/15/2024
Time: -- |
6/2024 | $-0.94 | 0.00% |
Earnings Summary
For their last quarter, Cartesian Therapeutics, Inc. (RNAC) reported earnings of -$1.97 per share, missing the Zacks Consensus Estimate of -$0.81 per share. This reflects a negative earnings surprise of 143.21%. Look out for RNAC's next earnings release expected on August 15, 2024. For the next earning release, we expect the company to report earnings of -$0.86 per share, reflecting a year-over-year increase of 75.45%.
Earnings History
Price & Consensus
Zacks News for RNAC
Wall Street Analysts Think Cartesian Therapeutics, Inc. (RNAC) Could Surge 141%: Read This Before Placing a Bet
RNAC: What are Zacks experts saying now?
Zacks Private Portfolio Services